Complete substitution with modified nucleotides suppresses the early interferon response and increases the potency of self-amplifying RNA
Description
Self-amplifying RNA (saRNA) will revolutionize vaccines and in situ therapeutics by enabling protein expression for longer duration at lower doses. However, a major barrier to saRNA efficacy is the potent early interferon response triggered upon
